/KMTS
KMTS Stock - KESTRA MEDICAL TECHNOLOGIES, LTD.
Healthcare|Medical - Instruments & SuppliesNASDAQ
$27.32+0.63%
+$0.17 (+0.63%) • Dec 19
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.90
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).57
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+3.4%upside
Target: $28.25
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for KMTS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$27.05 – $27.59
TARGET (TP)$28.25
STOP LOSS$25.13
RISK/REWARD1:0.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.00
52W High$30.00
52W Low$13.25
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $59.81M | $27.81M | $7.63M | N/A | N/A |
| Gross Profit | $24.21M | $362,000 | $-10,651,000 | N/A | N/A |
| Gross Margin | 40.5% | 1.3% | -139.6% | N/A | N/A |
| Operating Income | $-106,378,000 | $-85,063,000 | $-80,421,000 | $-32,708,000 | $-29,319,000 |
| Net Income | $-113,814,000 | $-94,120,000 | $-84,238,000 | $-34,101,000 | $-29,467,000 |
| Net Margin | -190.3% | -338.4% | -1104.0% | N/A | N/A |
| EPS | $-5.13 | $-2.04 | $-1.75 | $-0.69 | $-0.59 |
Company Overview
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
4
80%
Hold / Neutral
1
20%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
4 Bullish1 Neutral/Bearish
Price Targets
$28
Average Target
↑ 3.5% Upside
Now
$24
Low
$28
Average
$32
High
Based on 7 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 18th 2025 | BTIG Research | Initiation | Buy | $32 |
| March 31st 2025 | BofA Securities | Initiation | Buy | $30 |
| March 31st 2025 | Wolfe Research | Initiation | Outperform | $29 |
| March 31st 2025 | Goldman | Initiation | Neutral | $24 |
| March 31st 2025 | Stifel | Initiation | Buy | $28 |
| March 31st 2025 | Wells Fargo | Initiation | Overweight | $28 |
| March 31st 2025 | Piper Sandler | Initiation | Overweight | $27 |
Earnings History & Surprises
KMTSBeat Rate
50%
Last 2 quarters
Avg Surprise
+9.8%
EPS vs Estimate
Beats / Misses
1/1
Last 12 quarters
Latest EPS
$-0.62
Q4 2025
EPS Surprise History
Q3 21
No data
Q1 24
No data
Q2 24
No data
Q2 25
No data
Q3 25
No data
Q3 25
+30.3%
$-0.46vs$-0.66
Q4 25
-10.7%
$-0.62vs$-0.56
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Dec 11, 2025 | $-0.56 | $-0.62 | -10.7% | ✗ MISS |
Q3 2025 | Sep 11, 2025 | $-0.66 | $-0.46 | +30.3% | ✓ BEAT |
Q3 2025 | Jul 17, 2025 | — | $-1.05 | — | — |
Q2 2025 | Apr 17, 2025 | — | $-0.43 | — | — |
Q2 2024 | Apr 30, 2024 | — | $-0.45 | — | — |
Q1 2024 | Jan 31, 2024 | — | $-0.44 | — | — |
Q3 2021 | Jul 31, 2021 | — | $-0.27 | — | — |
Latest News
Goldman Sachs Maintains Neutral on Kestra Medical Techs, Raises Price Target to $25
➖ NeutralBenzinga•Dec 15, 2025, 05:50 PM
Wells Fargo Maintains Overweight on Kestra Medical Techs, Raises Price Target to $28
📈 PositiveBenzinga•Dec 12, 2025, 10:08 PM
Piper Sandler Maintains Overweight on Kestra Medical Techs, Raises Price Target to $30
📈 PositiveBenzinga•Dec 12, 2025, 02:42 PM
Kestra Medical Technologies shares are trading lower after the company reported mixed Q2 financial results.
📉 NegativeBenzinga•Dec 11, 2025, 09:23 PM
Kestra Medical Techs FY2026 Revenue expected $91.000M vs $88.138M Est
📈 PositiveBenzinga•Dec 11, 2025, 09:03 PM
Kestra Medical Techs Q2 EPS $(0.64) Misses $(0.59) Estimate, Sales $22.565M Beat $20.704M Estimate
➖ NeutralBenzinga•Dec 11, 2025, 09:02 PM
Reported Earlier, Kestra Medical Technologies Prices $138M Upsized Primary Public Offering Of 6M Common Shares At $23 Per Share
📈 PositiveBenzinga•Dec 3, 2025, 06:58 AM
Kestra Medical Technologies shares are trading lower after the company announced an offering of 5.5 million common shares. Also, the company reported preliminary Q2 results.
📉 NegativeBenzinga•Dec 1, 2025, 04:23 PM
Kestra Medical Technologies sees Q2 revenue between $22.2M and $22.6M
➖ NeutralSeeking Alpha•Dec 1, 2025, 03:52 PM
Kestra Medical Technologies, Ltd. Announces Primary Public Offering Of 5.5M Common Shares
➖ NeutralBenzinga•Dec 1, 2025, 12:18 PM
Kestra Medical Technologies Reports Preliminary Q2 FY26 Revenue Of $22.2M To $22.6M And Gross Profit Of $11M To $11.4M
📈 PositiveBenzinga•Dec 1, 2025, 12:08 PM
BTIG Initiates Coverage On Kestra Medical Techs with Buy Rating, Announces Price Target of $32
📈 PositiveBenzinga•Nov 18, 2025, 11:35 AM
Kestra Medical Presents Primary Results From ASSURE WCD Clinical Evaluation Post-Approval Study, At AHA Scientific Sessions 2025
➖ NeutralBenzinga•Nov 10, 2025, 02:54 PM
Kestra Medical Technologies Announces A Late-Breaking Presentation On November 10 Highlighting Primary Results From Its Ace-PAS Trial Of A Next-Generation Wearable Cardioverter Defibrillator System
📈 PositiveBenzinga•Nov 4, 2025, 01:08 PM
Kestra Medical Technologies shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26 sales guidance above estimates.
📈 PositiveBenzinga•Sep 12, 2025, 04:58 PM
Kestra Medical Techs Raises FY2026 Sales Guidance from $85.000M to $88.000M vs $85.074M Est
📈 PositiveBenzinga•Sep 11, 2025, 08:04 PM
Kestra Medical Techs Q1 EPS $(0.50) Beats $(0.85) Estimate, Sales $19.371M Beat $17.874M Estimate
📈 PositiveBenzinga•Sep 11, 2025, 08:03 PM
Frequently Asked Questions about KMTS
What is KMTS's current stock price?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) is currently trading at $27.32 per share. The stock has moved +0.63% today.
What is the analyst price target for KMTS?
The average analyst price target for KMTS is $28.25, based on 1 analyst.
What sector is KESTRA MEDICAL TECHNOLOGIES, LTD. in?
KESTRA MEDICAL TECHNOLOGIES, LTD. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NASDAQ exchange.
What is KMTS's market cap?
KESTRA MEDICAL TECHNOLOGIES, LTD. has a market capitalization of $1.59 billion, making it a small-cap company.
Does KMTS pay dividends?
No, KESTRA MEDICAL TECHNOLOGIES, LTD. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAZTA
Azenta, Inc.
$34.43
Mkt Cap: $1.6B
BLFS
BioLife Solutions, Inc.
$25.07
Mkt Cap: $1.2B
EVO
Evotec SE
$2.95
Mkt Cap: $1.0B
NEOG
Neogen Corporation
$7.20
Mkt Cap: $1.6B
NVCR
NovoCure Limited
$12.84
Mkt Cap: $1.4B
PGEN
Precigen, Inc.
$4.32
Mkt Cap: $1.3B
PLSE
Pulse Biosciences, Inc.
$15.26
Mkt Cap: $1.0B
STAA
STAAR Surgical Company
$25.14
Mkt Cap: $1.2B
TERN
Terns Pharmaceuticals, Inc.
$39.90
Mkt Cap: $3.6B
WVE
Wave Life Sciences Ltd.
$15.98
Mkt Cap: $2.6B
Explore stocks similar to KMTS for comparison